Four faces of cellular senescence
Open accessThe DOI matches its Crossref record; 133 of the 137 references it cites were found in a registry or an index; 10 of the 26 sources its claims cite were checked for support.
Abstract
Cellular senescence is an important mechanism for preventing the proliferation of potential cancer cells. Recently, however, it has become apparent that this process entails more than a simple cessation of cell growth. In addition to suppressing tumorigenesis, cellular senescence might also promote tissue repair and fuel inflammation associated with aging and cancer progression. Thus, cellular senescence might participate in four complex biological processes (tumor suppression, tumor promotion, aging, and tissue repair), some of which have apparently opposing effects. The challenge now is to understand the senescence response well enough to harness its benefits while suppressing its drawbacks.
Overview
CoChat Summary
## TL;DR
Cellular senescence is presented as an essentially irreversible growth arrest that suppresses tumor formation, but the paper argues it also has broader roles in tumor promotion, aging, and tissue repair. The authors frame these effects as arising from the senescence-associated secretory phenotype (SASP) and from the context in which senescent cells accumulate.
## Key findings
- Senescence is described as a crucial anticancer mechanism: in human and mouse premalignant lesions, senescent cells are abundant, but they are “markedly diminished” in the malignant tumors that develop from those lesions.
- Senescent cells can promote tumor progression in mouse xenografts: co-injection of senescent fibroblasts with premalignant epithelial cells enabled malignant cancer formation, and co-injection with fully malignant cells “markedly accelerates” tumor formation.
- Senescent cells may contribute to aging and degeneration: transgenic mice with chronically elevated p53 activity showed “shortened life span and premature aging,” including loss of fertility, osteoporosis, sarcopenia, dermal thinning, loss of subcutaneous fat, reduced hair growth, and retarded wound healing.
- In tissue repair, senescence appears beneficial: after acute liver injury, stellate cells undergo senescence, ECM production declines, MMP secretion increases, and mice impaired for senescence because of p53 or p16INK4a/p19ARF deficiencies developed “severe fibrosis” after injury.
## Methods
- This is a narrative review synthesizing prior studies across human tissues, mouse models, cell culture, and mouse xenografts.
- The paper compares senescent versus nonsenescent cells and summarizes experimental perturbations of p53, p16INK4a/pRB, Pten, Klotho, BubR1, p63, and CCN1 in relation to senescence phenotypes.
- Main analysis is interpretive and mechanistic: the authors connect published findings to a model in which senescence has temporally ordered phases, including early growth arrest, SASP induction, and later immune clearance or tissue-level effects.
## Limitations
- The paper itself states that evidence for senescence driving aging is “circumstantial,” and that cause-and-effect cannot yet be tested cleanly because organisms lacking senescence generally die prematurely of cancer.
- It also notes that there are “no definitive answers” for how senescence might promote late-life cancer.
- Evident from the text: many claims rely on mouse models, cell culture, and xenografts rather than direct demonstration in naturally occurring human disease.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
8 Valid · 1 Not valid · 8 Not checked · 28 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“thus p53 can be pro-aging or pro-longevity, depending on the physiological context (de Keizer et al., 2010).”
§ Four faces of cellular senescence > Cellular senescence and aging > Altered p53 function and aging.
What the sources say
- Supportedcites de Keizer et al., 2010 source
The paper states directly that p53 can be either pro-aging or pro-longevity depending on physiological context. It also explains that p53 can promote or retard aging depending on how its activity is regulated. (LLM, conf=0.95)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Low-level, chronic, “sterile” inflammation is a hallmark of aging that initiates or promotes most, if not all, major age-related diseases (Franceschi et al., 2007; Chung et al., 2009).”
§ Four faces of cellular senescence > Cellular senescence and aging > How might senescent cells promote age-related pathologies?
What the sources say
- Not checked — no full text of the sourcecites Franceschi et al., 2007 source
- Partly supportedcites Chung et al., 2009 sourceExperimental — accuracy not yet measured
The Introduction describes chronic, low-grade inflammation as a possible link between aging and the pathogenesis of many age-related diseases; the Conclusion calls it a primary factor underlying aging and numerous age-related diseases. The copy does not characterize the inflammation as “sterile,” and its references to many or numerous diseases do not substantiate “most, if not all.” Page numbers were not available in the indexed passages. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“which comprise a negative feedback loop to dampen NF-κB activity (Taganov et al., 2006; Freund et al., 2010).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion (page not specified in our copy) proposes that NF-κB induces miR-146 genes, which could reduce IRAK1 and TRAF6 levels and thereby dampen pathway activity. The claim presents that proposed negative-feedback effect as established; the paper says further studies are needed to determine miR-146’s exact role. (LLM, conf=0.85)
- Supportedcites Freund et al., 2010 source
The “Chromatin organization” section states that miR-146a/b provide negative feedback that inhibits NF-κB activity. The “microRNAs” section likewise describes them as part of an NF-κB feedback loop. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Whatever the case, the examples above, and a growing list of similar studies (Collado and Serrano, 2010), argue that cellular senescence restrains cancer by imposing a cell-autonomous block to the proliferation of oncogenically damaged/stressed cells (Fig. 2).”
§ Four faces of cellular senescence > Cellular senescence and tumor suppression
What the sources say
- Supportedcites Collado and Serrano, 2010 source
The Introduction (page not provided) describes oncogenically stressed cells stopping division through a cell-cycle arrest and identifies oncogene-induced senescence as a tumour-suppressor mechanism. The Preface adds that senescence stably blocks proliferation and that progression to malignancy requires evading it. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The induction of these miRNAs may prevent the SASP from generating persistent acute (robust) inflammation, which, unlike low-level chronic inflammation, is designed to be self-limiting (Taganov et al., 2006).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion proposes that induced miR-146 could dampen inflammatory signaling through a negative-feedback loop. It does not address the SASP or establish that these miRNAs prevent it from generating persistent acute inflammation; nor does it make the stated comparison with low-level chronic inflammation. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
30 more claims · 2 with their cited sources checked
Create a free account to see all 45 claims and every source verdict.
- It may state two separate claims as one. 4
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased numbers of senescent cells with age are an important contributor to the age-associated increase in inflammation because senescent cells secrete a large number of pro-inflammatory proteins (senescence-associated secretory phenotype, or SASP) (Rodier and Campisi, 2011).”
From The Aging Epigenome (2016) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescence can be triggered by multiple mechanisms, including those resulting in ROS production and oxidative stress (Kuilman et al., 2010; Rodier and Campisi, 2011).”
From mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis (2012) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cells undergoing damage-induced senescence are often cleared by the immune system, as several SASP factors are cytokines and chemokines that can modulate the local immune environment.2,3,5,70,71”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which exhibit various senescence-related phenotypes, like increased size of nucleoli, enlarged and overloaded lysosome, and secretion of senescence-associated secretory phenotype (SASP) factors.5,6,7”
From Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators (2024) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent findings have uncovered an additional beneficial effect of the senescence response and accompanying SASP: the ability to promote optimal repair of damaged tissue (59, 91, 145–147).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [147]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · cited 2×
“Moreover, to form a lethal tumor, cancer cells must acquire a greatly expanded growth potential and ability to proliferate while expressing activated oncogenes (Hanahan and Weinberg, 2000), traits that are suppressed by the senescence program.”
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“First, senescent cells increase with age in a variety of mammalian tissues (Dimri et al., 1995; Paradis et al., 2001; Melk et al., 2003; Erusalimsky and Kurz, 2005; Jeyapalan et al., 2007; Wang et al., 2009).”
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 2×
“…al., 1991; Shay et al., 1991; Bond et al., 1994; Lin et al., 1998; Schmitt et al., 2002; Beauséjour et al., 2003; Collins and Sedivy, 2003; Oren, 2003; Herbig et al., 2004; Jacobs and de Lange, 2004; Ohtani et al., 2004; Chen et al., 2005; Campisi and d’Adda di Fagagna, 2007; Rodier et al., 2007).”
Self-citationTaganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Cited by
Items 1,601–1,700 of 2,013
Libertini, G. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_26-2 · Cited by 2
Soto‐Pérez‐de‐Celis, E., & Hurria, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00060-8 · Cited by 3
Graziano, A. C. E., Ledda, C., Loreto, C., & Cardile, V. (2021) · Cellular Physiology and Biochemistry · doi:10.33594/000000379 · Cited by 2
Effect of Monocerin, a Fungal Secondary Metabolite, on Endothelial Cells
Gomes, T. C., Conrado, R., de Oliveira, R. C., Selari, P. J. R. G., de Melo, I. S., Araújo, W. L., Maria, D. A., & de Souza, A. O. (2023) · Toxins · doi:10.3390/toxins15050344 · Cited by 6
“Usually, a multinucleated and/or irregular cell nuclei and chromatin reorganization can be observed, showing a high number of granules [37,38].”
BackgroundCellular senescence and its pathogenic and therapeutic implications in autoimmune hepatitis
Czaja, A. J. (2024) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2024.2432480 · Cited by 2
“Clarification of the frequency, mechanisms, and consequences of cellular senescence in autoimmune hepatitis could suggest targeted therapeutic interventions [11,71,87,100,101].”
InfluentialSingh, D. P., Tripathi, A., Paul, A., Kaushal, S. K., Dixit, M., & Singh, D. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1693659 · Cited by 2
Aging and Chronic Respiratory Diseases: Novel Mechanisms
Sellarés, J., & Rojas, M. (2017) · Barcelona Respiratory Network · doi:10.24875/brn.m17000003 · Cited by 2
Obesity-Senescence-Breast Cancer: Clinical Presentation of a Common Unfortunate Cycle
Engin, A. B., & Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_27 · Cited by 2
Dehkordi, S. K., Sajedi, S., Heshmat, A., Orr, M. E., & Zare, H. (2025) · npj Aging · doi:10.1038/s41514-025-00235-y · Cited by 3
Gupta, R. V., Begum, M. Y., Kumar, R., Gupta, J., Nagraik, R., Panda, S. P., Abomughaid, M. M., Lakhanpal, S., Avinash, D., Osmani, R. A. M., et al. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10258-7 · Cited by 5
Payea, M. J., Dar, S. A., Anerillas, C., Martindale, J. L., Belair, C., Munk, R. B., Malla, S., Fan, J., Piao, Y., Yang, X., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.12.536613 · Cited by 2
Kozlowski, M. R., Grossman, B., Kneeland, A., Zemski, S., Crandell, A., & Kozlowski, R. E. (2020) · Japanese Journal of Ophthalmology and Research · doi:10.31546/2732-4516.1005 · Cited by 3
“Although cell senescence is thought to have important adaptive purposes, such as tumor suppression [1,4,5], it can also disrupt the integrity and functioning of tissues containing senescent”
BackgroundInfluentialSwanson, E. C. (2014) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2k30f · Cited by 1
“When these tumor suppressors fail to function properly, increased susceptibility to cancer results, due in part, to senescence not occurring (Rodier and Campisi, 2011; Zhang, 2007).”
BackgroundMechanisms of cell senescence in aging
von Zglinicki, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00003-2 · Cited by 3
Obesity and Metabolic Syndrome
Ettinger, S. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803013-4.00001-6 · Cited by 4
Diversity of CD28null T Cells in the Elderly: A Glimpse in a Biological Adaptation of Aging
Griffin, P. C., Michel, J. J., & Vallejo, A. N. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_87-1 · Cited by 2
DNA Damage Responses in Atherosclerosis
Shimada, K., Crother, T. R., & Arditi, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-404732-7.00010-1 · Cited by 4
Kinoshita, K., Satake, S., Matsui, Y., & Arai, H. (2019) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.72.221 · Cited by 3
The Role of Senescence in Hepatic Diseases
Pacheco-Rivera, R., Arellanes‐Robledo, J., de León, M. C. G., Shibayama, M., & Serrano‐Luna, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00023-0 · Cited by 3
(2020) · doi:10.1101/2020.12.20.423639 · Cited by 2
“Still, as with any form of senescence, if the resulting cells are not removed from their niche in a timely manner, an undesirable pro-tumorigenic facet can arise [Rodier and Campisi, 2011; Muñoz-Espín and Serrano, 2014; Gorgoulis et al., 2018; 2019].”
BackgroundGeneration and characterization of an immortalized equine osteoblast cell line
Lago, E. P., Roberts, S. J., Orriss, I. R., Lumsden, E. S., & Guest, D. J. (2026) · The Veterinary Journal · doi:10.1016/j.tvjl.2026.106573 · Cited by 3
Genome-Wide miRNA Screening for Genes Bypassing Oncogene-Induced Senescence
Guijarro, M. V., & Carnero, A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_5 · Cited by 2
Endothelial cellular senescence and tau accumulation: An interplay full of opportunities?
Oliveri, D., Moschetti, G., Griego, A., & Scarpa, E. (2024) · Ibrain · doi:10.1002/ibra.12154 · Cited by 2
“14,15 On the other hand, it can be detrimental as senescent cells decrease their functionality and become hypersecretory to promote a proinflammatory environment that is classically referred to as the senescence ‐ associated secretory phenotype (SASP).”
BackgroundMa, W., Liu, C., Pu, J., Liu, Z., Hu, N., Li, Y., Chen, D., Li, H., & Ma, H. (2025) · Andrology · doi:10.1111/andr.70119 · Cited by 4
“53 p53,p21proteinsarealsothoughttobeassociatedwith cellular senescence and are activated in response to oxidative stress induced by D -galactose in mice.”
Peroxiredoxin 6: A Regulatory Target in Cellular Senescence and Age-Related Diseases
Wang, H., Zhao, Y., Zhou, F., Chen, F., Chen, T., Wang, J., Liu, H., Sun, C., Zhou, R., Hu, W. M., et al. (2025) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0793 · Cited by 7
Olcay, L., Billur, D., Erdemlı, E., BASKIN, S. E., BALCI, H. F., & Yetgin, S. (2015) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1408-149 · Cited by 3
“In our patients, we could not test all features of cellular senescence, but not all senescent cells express all possible senescence markers (5).”
BackgroundAljada, A. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0168 · Cited by 2
“44,45 Most senescent cells seem to express p16 INK4a , a cyclin-dependent kinase inhibitor and tumor suppressor that enforces growth arrest by activating pRb. 46,47 Activation of p16 INK4a in WBCs could be one of the mechanisms by which metformin exerts its anticancer effects.”
Vusser, K. D., Winckelmans, E., Martens, D. S., Lerut, E., Kuypers, D. R. J., Nawrot, T. S., & Naesens, M. (2020) · Aging · doi:10.18632/aging.103098 · Cited by 2
“Telomeres are complexes of tandem TTAGGG repeats of 5000 to 15000 base pairs that reside at the ends of chromosomes [1].”
BackgroundLe fibroblaste sénescent : un catalyseur de la tumorigenèse
Brassart‐Pasco, S., & Hornebeck, W. (2012) · Médecine & longévité · doi:10.1016/j.mlong.2012.02.004 · Cited by 1
The Biology of Aging and Cancer: A Complex Association
Rajput, M., Dwivedi, L., Sabarwal, A., & Singh, R. P. (2020) · Springer eBooks · doi:10.1007/978-981-32-9005-1_21 · Cited by 1
Lipocalin 2 dictates cancer cell plasticity elicited by therapy-induced senescencePreprint
Morales-Valencia, J., Lau, L., Martí-Nin, T., Özerdem, U., & David, G. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.08.483463 · Cited by 1
“Cellular senescence refers to the stable cell proliferation arrest caused by either telomere shortening, oncogene activation or genotoxic stress, all of which converge towards the activation of a sustained DNA damage response (DDR) (4).”
BackgroundGilbert, C. A. (2011) · eScholarship@UMassChan · doi:10.13028/a7fz-f103 · Cited by 1
Muller’s ratchet as a mechanism of frailty and multimorbidityPreprint
Govindaraju, D. R., & Innan, H. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/439877 · Cited by 1
Yılmaz, S., Bedіr, E., & Ballar, P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.12.607434 · Cited by 1
Modeling Aging and Age-Associated Pathology in Zebrafish
houcke, J. V., Bollaerts, I., Groef, L. D., & Moons, L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00025-7 · Cited by 2
Adult Cardiac Stem Cells: Identity, Location and Potential
Ellison, G. M., Smith, A. J., Waring, C. D., Henning, B. J., Burdina, A. O., Polydorou, J., Vicinanza, C., Lewis, F., Nadal‐Ginard, B., & Torella, D. (2013) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4614-9569-7_4 · Cited by 2
“Although a universal marker exclusively expressed in senescent cells has not been identifi ed, most senescent cells express p16 INK4a , a cyclin-dependent kinase inhibitor and tumour suppressor, which is not commonly expressed by quiescent or terminally differentiated cells [ 147 , 148 ].”
BackgroundMolecular mechanisms of aging in MTDNA mutator mice
Edgar, D. (2011) · Figshare · Cited by 1
Vukojević, M., Ajdžanović, V. Z., Stančić, A., Otašević, V., Filipović, B. R., Živanović, J., & Miler, M. (2026) · BioFactors · doi:10.1002/biof.70119 · Cited by 1
Kawaguchi, T., Ide, T., Kondo, R., Nomura, Y., Arinaga‐Hino, T., Kuwahara, R., Amano, K., Sano, T., Akiba, J., Ohshima, K., et al. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8024 · Cited by 1
“Senescent cells secrete senescence-associated secretory phenotype (SASP), which affects neighboring cells and causes chronic inflammation and tumorigenesis (38).”
Balancing senescence and apoptosis: therapeutic insights into aging and cancer
Jan, N., Sofi, S., Mir, A. A., Masoodi, G., & Mir, M. A. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05355-3 · Cited by 4
“The term "therapy-induced senescence" describes the results of any treatment such as immunotherapy or chemotherapy that cells receive [20].”
Sedivy, J. M., & van Deursen, J. M. (2013) · Longevity & Healthspan · doi:10.1186/2046-2395-2-7 · Cited by 1
“© 2013 Sedivy and van Deursen; licensee BioM Creative Commons Attribution License (http:/ distribution, and reproduction in any medium chromatin, and even nutrient imbalances and illdescribed cell culture stresses [5-9].”
BackgroundEffect of Chronic Benzalkonium Chloride Exposure on Senescence in Trabecular Meshwork Cells
Park, J., Lee, S. J., Lee, K. W., & Kim, J. (2019) · Journal of the Korean Ophthalmological Society · doi:10.3341/jkos.2019.60.1.55 · Cited by 1
Araújo, A. R., Gaspar-Silva, F., & Logarinho, E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.26.634919 · Cited by 1
Lautrup, S., Anisimov, A. S., Lagartos-Donate, M. J., & Fang, E. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91617-2.00010-9 · Cited by 4
Khursheed, F., Mayer, A. C. R., Gupta, M., Ahmad, M. I., Khan, M., & Lawrence, A. J. (2026) · Atmospheric Environment · doi:10.1016/j.atmosenv.2026.121852 · Cited by 1
Cellular Senescence in Aging Mucosal Tissues Is Accentuated by Periodontitis
Ebersole, J. L., & González, O. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-42990-4_8 · Cited by 1
Radiation-induced senescent melanoma cells secrete soluble factors that trigger bystander senescence
Salvarredi, L. A., Agüero, H., Millán, M., Marra, M. F., Callegari, E. A., Castro, C., & Lopez, L. (2025) · International Journal of Radiation Biology · doi:10.1080/09553002.2025.2505525 · Cited by 2
“Moreover, the effects of individual SASP factors are often context-dependent, influenced by the particular cellular and tissue environment (Rodier and Campisi 2011).”
Age-Linked Non-Transmissible Diseases
Swynghedauw, B. (2019) · Practical issues in geriatrics · doi:10.1007/978-3-030-15111-9_6 · Cited by 1
Osteoimmune senescence in aging-related bone diseases
Li, H., Yang, Y., & Zhu, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1892334 · Cited by 5
“In skeletal tissues, these responses may occur in osteocytes, osteoblast-lineage cells, stromal cells, chondrocytes, endothelial cells, and immune cells (12, 58).”
The Biology of Death: How Dying Shapes Cells, Organisms, and Populations
Howard, G. C. (2021) · doi:10.1093/oso/9780190687724.001.0001 · Cited by 2
EXD2 and WRN exonucleases are required for interstrand crosslink repair in DrosophilaPreprint
Chennuri, P. R., Cox, L. S., & Saunders, R. D. C. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/284307 · Cited by 2
“may have the potential to alleviate or delay the adverse effects of cell senescence caused by some genotoxic stresses – as accumulation of senescent cells is detrimental to tissue integrity and function [69-73], such agents would have potential to alleviate diseases of ageing.”
BackgroundYang, C. J., Bromma, K., Sung, W., Schuemann, J., & Chithrani, D. B. (2021) · doi:10.32920/14638683 · Cited by 1
Yang, C. J., Bromma, K., Sung, W., Schuemann, J., & Chithrani, D. B. (2021) · doi:10.32920/14638683.v1 · Cited by 1
Senolytic potential of shea-derived amyrins in senescent fibroblasts
Hirose, M., Watanabe, S., Fujita, Y., Ohta, S., & Sugimoto, M. (2025) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbaf153 · Cited by 1
Ganova, P., Belenska-Todorova, L. F., Doncheva, T., & Ivanovska, N. (2017) · Journal of Advances in Medical and Pharmaceutical Sciences · doi:10.9734/jamps/2017/37839 · Cited by 1
(2018) · doi:10.1101/448837 · Cited by 1
“…RT-qPCR analyses of p21 and p16, two cell cycle inhibitors involved in p53- and retinoblastoma protein (Rb)-mediated senescence, respectively (Rodier & Campisi, 2011), showed that TNF-α induced a strong up-regulation of p21 expression while IL-1β and IL-6 mainly engaged in inducing p16…”
BackgroundA case of palatal ancient neurofibroma: Unmasking the histological masquerader
Krishnan, R. P., Ramani, P., Pandiar, D., Monica, K., & Kizhakkoottu, S. (2022) · Oral Oncology · doi:10.1016/j.oraloncology.2022.105726 · Cited by 1
From Lasers to Longevity: Exploring Energy-Based Devices as Senotherapeutic Tools in Dermatology
Hrițcu, O. M. C., Costan, V. V., Toader, Ș. V., Branisteanu, D. E., & Toader, M. P. (2025) · Cosmetics · doi:10.3390/cosmetics12050201 · Cited by 1
(2017) · doi:10.1101/238709 · Cited by 41
“…integrated in many signalling events communicating extracellular cues to epigenetic changes, examples of which include adipogenesis, haematopoiesis, innate immunity, female fertility, skin function, apoptosis, and cellular senescence (Nerlov, 2008; Rodier and Campisi, 2011; Tsukada et al., 2011).”
BackgroundTyutyunyk‐Massey, L., Haqqani, S., Mandava, R., Kentiba, K., Dammalapati, M., Dao, N., Haueis, J. R. S., Gewirtz, D. A., & Landry, J. W. (2018) · Advances in cancer research · doi:10.1016/bs.acr.2018.02.001 · Cited by 1
“…often include enlarged and flattened morphology, upregulation of cell cycle control proteins such as Rb, p16, and p21 and increased expression of the lysosomal senescence-associated β-galactosidase (SA-β-Gal) (Lee et al., 2006; Rodier & Campisi, 2011; Toussaint, Medrano, & von Zglinicki, 2000).”
BackgroundOrganelle Stress and mTOR in Aging-Associated Inflammation
Pani, G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397803-5.00014-9 · Cited by 1
Ulfah, F., Octaviani, H., Handono, K., & Kalim, H. (2019) · AIP conference proceedings · doi:10.1063/1.5110006 · Cited by 1
Cellular Senescence and Its Relation with Telomere
Arenas-Aranda, D. J., Hernández-Caballero, M. E., & Salamanca‐G�mez, F. (2012) · InTech eBooks · doi:10.5772/32949 · Cited by 1
“These cells can exhibit diverse changes that in their entirety can aid us in defining the senescent phenotype (Rodier & Campisi, 2011).”
MASLD/MASH-related hepatocellular carcinoma in a 43-year-old morbidly obese patient
Kawaguchi, T., Shimose, S., Kondo, R., Sato, T., Hisaka, T., Yano, H., & Kawaguchi, T. (2024) · Kanzo · doi:10.2957/kanzo.65.131 · Cited by 1
Martins-Silva, R., Kaizeler, A., & Barbosa‐Morais, N. L. (2026) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqag057 · Cited by 2
New Horizons in Myotonic Dystrophy Type 1: Cellular Senescence as a Therapeutic Target
Légaré, C., Berglund, J. A., Duchesne, É., & Dumont, N. A. (2024) · BioEssays · doi:10.1002/bies.202400216 · Cited by 2
The role of telomere damage in cardiomyocyte ageing
Anderson, R. K. (2016) · Cited by 1
Combination nanoadjuvant-based vaccine against influenza virus for older adults
Senapati, S. (2020) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-20210114-134 · Cited by 1
Diversity of CD28null T Cells in the Elderly: A Glimpse in a Biological Adaptation of Aging
Griffin, P. C., Michel, J. J., & Vallejo, A. N. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_87 · Cited by 1
Cellular Senescence as a Barrier to Environmental Carcinogenesis
Vergel, M. (2014) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s3-004 · Cited by 1
Healthy aging and aging-related kidney diseases: lessons from centenarians
Yamamoto, S., Arai, Y., Kosaka, T., Matsumoto, M., Yamada, R., Yoshikawa, T., & Yanagita, M. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf284 · Cited by 3
“Subsequent studies have revealed additional hallmarks of senescence, including resistance to apoptosis and the development of a SASP [53 ].”
Contribution of Nucleic Acids in the Pathogenesis of Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00004-5 · Cited by 1
Influence of the microenvironment on the modulation of the host response by the typhoid toxin
(2020) · doi:10.1101/2020.06.04.133686 · Cited by 1
“…local microenvironment ranging from maintaining tissue homeostasis (e.g. tissue remodeling or repair), generating a tumorigenic barrier to prevent cellular transformation or exerting tumor promoting effects, in a context-dependent manner (reviewed in (Faget et al., 2019; Rodier and Campisi, 2011)).”
BackgroundKatsuumi, G., & Minamino, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00007-9 · Cited by 2
Libertini, G. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_26-1 · Cited by 1
Li, Z., Chi, H., Zhu, H., Huang, P., Huang, L., & Lin, W. (2026) · Science China Chemistry · doi:10.1007/s11426-025-3334-8 · Cited by 1
Svatek, R. S., & Curiel, T. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4732-0_13 · Cited by 1
Özen, Ç., Ceylan‐Ünlüsoy, M., Öztürk, M., & Bozdağ‐Dündar, O. (2017) · Medicinal Chemistry Research · doi:10.1007/s00044-017-2037-0 · Cited by 1
Progenitor Cells from the Adult Heart
Ellison, G. M., & Lewis, F. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-56106-6_2 · Cited by 1
Xue, T., Zheng, J.-Q., Xu, Y.-F., Guo, Y., Lu, B.-Q., Zhang, T.-T., Wang, J.-W., Zhao, Z.-X., Wu, X., Ding, H., et al. (2026) · Aquaculture Science and Management · doi:10.1186/s44365-026-00039-5 · Cited by 1
“…to vertebrate systems, particularly mammalian stem cell cultures, marine invertebrate qui-escence shares commonalities with cellular senescence, a permanent proliferative arrest associated with aging and stress responses in mammals, often mediated by pathways like p53/p21 and p16/Rb [84].”
Howard, G. C. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780190687724.003.0004 · Cited by 1
Modulating Proliferation, Migration and Differentiation of Mesenchymal Stem Cells Using Interleukins
Srinivasan, S., & Ghone, N. V. (2024) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x313750240524115446 · Cited by 1
Senotherapeutic approach to age-related endocrine diseases
Turgut, Ş., & Andican, G. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.02.009 · Cited by 1
Single-cell profiling of skeletal muscle reveals a novel senolytic target: CRYABPreprint
Limbad, C., Doi, R., McGirr, J., Ciotlos, S., Pérez, K., Daya, R., Campisi, J., & Melov, S. (2021) · Research Square · doi:10.21203/rs.3.rs-456991/v1 · Cited by 1
Self-citationGenetic and Epigenetic Influences on Cutaneous Cellular Senescence
Sarkar, T. J., Hermsmeier, M., Ross, J. L., & Herron, G. S. (2021) · Physiology · doi:10.5772/intechopen.101152 · Cited by 1
Blander, H. D., Tonon, L., Fauvet, F., Pommier, R. M., Lamblot, C., Benhassoun, R., Angileri, F., Gibert, B., Ouzounova, M., Morel, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.23.497180 · Cited by 1
Integrin α3β1 signaling in regulation of the SK-Mel-147 melanoma cell senescence
Morozevich, G. E., Kozlova, N. I., Геворкян, Н. М., & Berman, A. E. (2022) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20226801039 · Cited by 1
The Links Between Osteoporosis and Sarcopenia in Women
Blümel, J. E., Arteaga, E., Vallejo, M. S., & Chea, R. (2019) · Springer eBooks · doi:10.1007/978-3-030-13936-0_26 · Cited by 1
Hypertension and COVID-19 — current state and prospects
Долгалев, И. В., Самойлова, Ю. Г., Maksimova, K. Y., Ivanova, A. Y., Матвеева, М. В., Старовойтова, Е. А., Кириллова, Н. А., & Fedosenko, S. V. (2023) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2023-29-6-557-567 · Cited by 6
Osterhage, M. R., Knabbe, C., & Hendig, D. (2026) · Antioxidants · doi:10.3390/antiox15020241 · Cited by 1
“The DNA damage in both types of senescence leads to the stabilization of one or more of the cyclin-dependent kinase inhibitors p53/p21 and p16 [12].”
Cellular senescence and inflammageing: from mechanisms to senotherapeutic interventions
Chmielewski, P. P. (2026) · Biogerontology · doi:10.1007/s10522-026-10477-2 · Cited by 3
“Cellular senescence is a biologically heterogeneous and context-dependent cellular state with both adaptive and pathological consequences (Rodier and Campisi 2011; Demaria et al. 2014; Muñoz-Espín and Serrano 2014; Regulski 2017), characterised by durable cell-cycle arrest, epigenetic remodelling,…”
Master Switch of Mitochondrial Biogenesis: A Clinical Target for Health Span Enhancement?
Mendelsohn, A. R., & Larrick, J. W. (2011) · Rejuvenation Research · doi:10.1089/rej.2011.1194 · Cited by 2
“The absence of telomerase in somatic cells has been hypothesized to be an anticancer adaptation, 5 because it must be overcome for a transformed cell to form a clinically relevant tumor.”
Haj‐Mirzaian, A., Afshari, K., & Abdolghaffari, A. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-50287-4_24 · Cited by 3
Genetically Engineered Dental Stem Cells for Regenerative Medicine
Solovyeva, V. V., Kiyasov, A. P., & Rizvanov, A. A. (2016) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-28947-2_5 · Cited by 1
Detection of the Ubiquitinome in Cells Undergoing Oncogene-Induced Senescence
Zhu, H., Le, L., Tang, H., Speicher, D. W., & Zhang, R. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_12 · Cited by 1
“Cellular senescence is a state of stable cell growth arrest and is implicated in many biological processes, including embryogenesis (1), aging, tissue repair and tumor suppression (2, 3, 4).”
BackgroundCellular Senescence Controlled by p53 is a Barrier to Environmental Carcinogenesis
Vergel, M. (2015) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000208 · Cited by 1
“It is characterized by changes in transcription, chromatin conformation, cytoplasmic and nuclear morphology, DNA damage signaling, and a strong increase in the secretion of pro-inflammatory cytokines [12-14].”
Background
Metadata
- Authors
- Rodier, F., & Campisi, J.
- Affiliations
- The Research Centre of the University of Montreal Hospital Centre/Institut du Cancer de Montréal, Montreal, Quebec, H2L 4M1 Canada 1
- Buck Institute for Research on Aging (US)
- Corresponding author
- Campisi, Judith
- ORCID
- Campisi, Judith
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2011-02-14
- Volume
- 192
- Issue
- 4
- Pages
- 547-556
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3044123
- OpenAlex
- W2077450385
- Cited by
- 2,070
- References
- 137
- Citations by year
- 2026: 65 · 2025: 94 · 2024: 101 · 2023: 131 · 2022: 113 · 2021: 164 · 2020: 175 · 2019: 154 · 2018: 164 · 2017: 160 · 2016: 162 · 2015: 162 · 2014: 147 · 2013: 126 · 2012: 108
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- U.S. Department of Energy
- Cancer Research Society
- Institut Du Cancer de Montréal
- National Institutes of Health
- National Cancer Institute
- Institute of Cancer Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, tumor suppression, tumor promotion, aging, tissue repair, inflammation, tumor progression, senescence-associated secretory phenotype, senescence-associated inflammation
- MeSH terms
- Aging, Animals, Humans, Models, Biological, Neoplasms, Wound Healing, Signal Transduction, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.